This Voya Financial Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
Analysts downgraded Voya, Pacira, Genworth, and more, with price-target changes for several.
Stocks · News reference
Analysts downgraded STZ, TYL, DK, CRBU and PSX; price targets changed for STZ, TYL, DK and PSX.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Analysts downgraded Voya, Pacira, Genworth, and more, with price-target changes for several.
U.S. stock futures fell, with Dow futures down 450 points. Argenx sank 8.7% after a Sjögren’s trial was halted for futility; others also slid.
HC Wainwright & Co. analyst Robert Burns downgrades Caribou Biosciences (NASDAQ:CRBU) from Buy to Neutral.
Analysts raised targets for Everpure, Eli Lilly and Delek US, while cutting targets for Constellation, Tyler, ArriVent and Netflix.
Mizuho analyst Nitin Kumar downgrades Delek US Holdings (NYSE:DK) from Outperform to Neutral and raises the price target from $66 to $83.